About
Welcome to the Regenerative Medicine Foundation, a not-for-profit organization created to advance new treatments and therapies based on tissue engineering and regenerative medicine. We believe that integrating life science and engineering disciplines will bring new clinical approaches to patients for the treatment of diseases affecting a wide range of tissues and organs.
By fostering collaboration between public and private initiatives, we can capitalize on the academic, industry and governmental resources in regenerative medicine and expedite the pace of research so that innovative therapies are developed and delivered to patients more rapidly. The Regenerative Medicine Foundation has been designed to be the connection point for a variety of interests, with education and interdisciplinary collaboration serving as the core and sustaining values of the organization.
Mission
The mission of the Regenerative Medicine Foundation is to facilitate the development and cures for diseases through the science of regenerative medicine.
The Regenerative Medicine Foundation advocates for increased medical research, funds basic and clinical investigations, promotes the training and education of scientists, and facilitates the translation of therapies to patients.
History
The Regenerative Medicine Foundation was formed in 2005 by Dr. Anthony Atala.
The Foundation hosted one of the very first meetings with the U.S. Food and Drug Administration (FDA) around the topic of regenerative medicine.
In 2006, the Foundation was instrumental in the formation of STRAC, the Soldier Treatment and Regeneration Consortium, a national partnership of leading military and academic research centers and industry. STRAC formed the basis for the Armed Forces Institute of Regenerative Medicine (AFIRM).
On July 1, 2009, the Foundation became the Founding member of the Alliance for Regenerative Medicine, a Washington, DC-based public policy and patient advocacy group focused on the field of regenerative medicine. The Alliance will advocate for increased federal funding for regenerative medicine research, healthcare reform and legislation that impacts regulatory and reimbursement policy. Charter members of the Alliance include Johnson & Johnson, Pfizer, Geron, Kleiner Perkins Caufield and Byers, the University of Washington and the Wake Forest Institute for Regenerative Medicine. Additional Charter members will be announced later in July.
In 2009, the Foundation announced the first annual Translational Regenerative Medicine Forum, to be held in Winston-Salem, NC, April 6-8, 2010. The conference focuses on best practices in clinical trials and GMP facilities, as well providing a forum to discuss regulatory and reimbursement challenges. In addition, the conference features a venture forum to introduce early-stage and later-stage companies to accredited and institutional investors.
